Reviewing Growlife (PHOT) and Its Rivals

Risk and Volatility

Growlife has a beta of 2.3, meaning that its share price is 130% more volatile than the S&P 500. Comparatively, Growlife’s competitors have a beta of 1.22, meaning that their average share price is 22% more volatile than the S&P 500.

Insider & Institutional Ownership

40.3% of shares of all “CONSM PD – MISC DIS” companies are held by institutional investors. 2.8% of Growlife shares are held by insiders. Comparatively, 21.6% of shares of all “CONSM PD – MISC DIS” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Growlife and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Growlife	N/A	N/A	N/A
Growlife Competitors	-12.19%	-0.55%	-0.70%

Valuation & Earnings

This table compares Growlife and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Growlife	N/A	-$4.48 million	0.00
Growlife Competitors	$2.76 billion	$79.78 million	-6.40

Growlife’s competitors have higher revenue and earnings than Growlife. Growlife is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Growlife beats its competitors on 5 of the 9 factors compared.

About Growlife

GrowLife, Inc. focuses on the functional mushroom business. It processes, stores, markets, distributes, and sells fresh and dried mushroom products. The company was founded in 2012 and is headquartered in Kirkland, Washington.